Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Dravet syndrome
Pharma
2 players vied before UCB emerged to buy Zogenix for $1.9B
An SEC filing on UCB's recent acquisition of Zogenix details the negotiations it took to get the deal done.
Kevin Dunleavy
Feb 1, 2022 5:24pm
Zogenix's Fintepla ready to challenge GW Pharma in rare epilepsy
Jun 26, 2020 11:15am
GW Pharma wins historic FDA nod for cannabis-based drug
Jun 25, 2018 5:25pm
